These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 2176094)

  • 21. Studying DNA topoisomerase I-targeted drugs in the yeast. Saccharomyces cerevisiae.
    Woo MH; Vance JR; Bjornsti MA
    Methods Mol Biol; 2001; 95():303-13. PubMed ID: 11089242
    [No Abstract]   [Full Text] [Related]  

  • 22. Topoisomerase as target for antibacterial and anticancer drug discovery.
    Kathiravan MK; Khilare MM; Nikoomanesh K; Chothe AS; Jain KS
    J Enzyme Inhib Med Chem; 2013 Jun; 28(3):419-35. PubMed ID: 22380774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent advances in the development of dual topoisomerase I and II inhibitors as anticancer drugs.
    Salerno S; Da Settimo F; Taliani S; Simorini F; La Motta C; Fornaciari G; Marini AM
    Curr Med Chem; 2010; 17(35):4270-90. PubMed ID: 20939813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural inhibitors of DNA topoisomerase I with cytotoxicities.
    Han HJ; Tan NH; Zeng GZ; Fan JT; Huang HQ; Ji CJ; Jia RR; Zhao QS; Zhang YJ; Hao XJ; Wang LQ
    Chem Biodivers; 2008 Jul; 5(7):1364-8. PubMed ID: 18649302
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Biological function of DNA topoisomerases and its implication in cancer chemotherapy].
    Andoh T; Okada K; Oguro M
    Gan To Kagaku Ryoho; 1988 Jan; 15(1):1-14. PubMed ID: 2827584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topoisomerase Inhibitors and Targeted Delivery in Cancer Therapy.
    You F; Gao C
    Curr Top Med Chem; 2019; 19(9):713-729. PubMed ID: 30931860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA topoisomerases as targets of therapeutics: an overview.
    Wang JC
    Adv Pharmacol; 1994; 29A():1-19. PubMed ID: 7826853
    [No Abstract]   [Full Text] [Related]  

  • 28. Diversity of DNA topoisomerases I and inhibitors.
    Pommier Y
    Biochimie; 1998 Mar; 80(3):255-70. PubMed ID: 9615865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Inhibitors of DNA topoisomerases].
    Andoh T
    Gan To Kagaku Ryoho; 1997 Sep; 24(11):1526-35. PubMed ID: 9309151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA topoisomerases: essential enzymes and lethal targets.
    Chen AY; Liu LF
    Annu Rev Pharmacol Toxicol; 1994; 34():191-218. PubMed ID: 8042851
    [No Abstract]   [Full Text] [Related]  

  • 31. Quantification of topoisomerase-DNA complexes in leukemia cells from patients undergoing therapy with a topoisomerase-directed agent.
    Ellis AL; Nowak B; Plunkett W; Zwelling LA
    Cancer Chemother Pharmacol; 1994; 34(3):249-56. PubMed ID: 8004759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA topoisomerases as targets for the anticancer drug TAS-103: primary cellular target and DNA cleavage enhancement.
    Byl JA; Fortune JM; Burden DA; Nitiss JL; Utsugi T; Yamada Y; Osheroff N
    Biochemistry; 1999 Nov; 38(47):15573-9. PubMed ID: 10569941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Marine bromophenol bis(2,3-dibromo-4,5-dihydroxybenzyl) ether, induces mitochondrial apoptosis in K562 cells and inhibits topoisomerase I in vitro.
    Liu M; Zhang W; Wei J; Qiu L; Lin X
    Toxicol Lett; 2012 Jun; 211(2):126-34. PubMed ID: 22484147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Yeast systems for demonstrating the targets of anti-topoisomerase II agents.
    Nitiss JL; Nitiss KC
    Methods Mol Biol; 2001; 95():315-27. PubMed ID: 11089243
    [No Abstract]   [Full Text] [Related]  

  • 35. Topoisomerase I poisons and suppressors as anticancer drugs.
    Bailly C
    Curr Med Chem; 2000 Jan; 7(1):39-58. PubMed ID: 10637356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA topoisomerases as targets for cancer therapy.
    Ross WE
    Biochem Pharmacol; 1985 Dec; 34(24):4191-5. PubMed ID: 3000380
    [No Abstract]   [Full Text] [Related]  

  • 37. Commentary: topoisomerases as targets in acute leukemia: I, II, I plus II or none?
    Malek SN; Gore SD
    Leuk Res; 2003 Jan; 27(1):1-3. PubMed ID: 12479845
    [No Abstract]   [Full Text] [Related]  

  • 38. DNA topoisomerase-targeting antitumor agents and drug resistance.
    Takano H; Kohno K; Matsuo K; Matsuda T; Kuwano M
    Anticancer Drugs; 1992 Aug; 3(4):323-30. PubMed ID: 1330080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apoptosis induced by DNA topoisomerase I and II inhibitors in human leukemic HL-60 cells.
    Solary E; Bertrand R; Pommier Y
    Leuk Lymphoma; 1994 Sep; 15(1-2):21-32. PubMed ID: 7858500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study of dihydroxylated 2,6-diphenyl-4-aryl pyridines.
    Karki R; Song C; Kadayat TM; Magar TB; Bist G; Shrestha A; Na Y; Kwon Y; Lee ES
    Bioorg Med Chem; 2015 Jul; 23(13):3638-54. PubMed ID: 25936262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.